Back to company

BIOLIT ApS: Financial statements 2022

CVR: 10068460

BIOLIT ApS (CVR 10068460) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,382,658 and a net result of DKK 3,164,066 compared with DKK 1,567,561 the year before. That is an increase of 30.3% compared with the year before. Equity amounted to DKK 13,550,280. The solvency ratio was 61.5%.

Gross Profit
2,382,658 kr.
Profit/Loss
3,164,066 kr.
Equity
13,550,280 kr.
Total Assets
22,046,913 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-2.4 mio.3.2 mio.13.6 mio.0
2021-1.8 mio.1.6 mio.10.4 mio.0
2020-1.5 mio.1.7 mio.8.8 mio.-
2019-2 mio.1.5 mio.7.1 mio.-
2018-1.3 mio.954 t.5.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BIOLIT ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About BIOLIT ApS

BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.